Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.456, 2004-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Neonatal group B streptococcal sepsis: prevention worthwhile?
Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. :
Access to resources
Recommend
Dyspepsia: which non-invasive management strategy worthwhile?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. :
Patient education during H. pylori eradication therapy worthwhile?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. :
Is early intervention with biological agents worthwhile in RA?
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
Folate supplementation + methotrexate worthwhile in RA?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :